Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 14/20 | 0.69 |
| ▸ | HTR1D | P28221 | 14/20 | 0.69 |
| ▸ | HTR1B | P28222 | 14/20 | 0.69 |
| ▸ | HTR2C | P28335 | 5/20 | 0.51 |
| ▸ | HTR6 | P50406 | 5/20 | 0.51 |
| ▸ | HTR2A | P28223 | 4/20 | 0.51 |
| ▸ | HTR7 | P34969 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6720400 | 0.88 | MAPT (0.58) | HTR1AHTR1DHTR1BHTR2CHTR6 | |
| SCHEMBL6717660 | 0.88 | HTR1A (0.64) | HTR1AHTR1DHTR1BHTR2CHTR6 | |
| SCHEMBL6718238 | 0.87 | HTR1A (0.69) | HTR1AHTR1DHTR1BHTR2CHTR6 | |
| SCHEMBL6716646 | 0.86 | HTR1A (0.64) | HTR1AHTR1DHTR1BHTR2CHTR6 | |
| SCHEMBL6717734 | 0.85 | HTR1A (0.56) | HTR1AHTR1DHTR1BHTR2CHTR6 | |
| SCHEMBL6714774 | 0.85 | HTR1A (0.56) | HTR1AHTR1DHTR1BHTR2CHTR6 | |
| SCHEMBL6714920 | 0.85 | HTR1A (0.56) | HTR1AHTR1DHTR1BHTR2CHTR6 | |
| SCHEMBL6717524 | 0.85 | HTR1A (0.56) | HTR1AHTR1DHTR1BHTR2CHTR6 | |
| SCHEMBL6716746 | 0.84 | HTR1A (0.55) | HTR1AHTR1DHTR1BHTR2CHTR6 | |
| SCHEMBL6718801 | 0.84 | HTR1A (0.65) | HTR1AHTR1DHTR1BHTR2CHTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1313477-A4 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORP (US) | 2004-03-03 | — | — | EP | claimed |
| EP-1313477-A1 | COMPOUNDS AND METHODS | SmithKline Beecham Corporation (US) | 2003-05-28 | — | — | EP | claimed |
| WO-2002005819-A1 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 2002-01-24 | — | — | WO | claimed |
| EP-1313477-A4 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORP (US) | 2004-03-03 | — | — | EP | disclosed |
| EP-1313477-A1 | COMPOUNDS AND METHODS | SmithKline Beecham Corporation (US) | 2003-05-28 | — | — | EP | disclosed |
| WO-2002005819-A1 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 2002-01-24 | — | — | WO | disclosed |